Converting adults with sickle cell disease from full agonist opioids to buprenorphine: A reliable method with safety and early evidence of reduced acute care utilization.

Published in:

American Journal of Hematology, 2022, v. 97, n. 11, p. 1435, doi. 10.1002/ajh.26699

By:

• David, Mandy S.;
• Jones, Jennifer;
• Lauriello, Ashley;
• Nnake, Ijeoma;
• Plazas Montana, Manuela;
• Lasko, Kyra;
• Buri‐Nagua, Carlos;
• Olagbaju, Yetunde;
• Williams, Elizabeth;
• Sears, Matthew;
• Salzberg, Benjamin;
• Lanzkron, Sophie M.;
• Carroll, C. Patrick

Publication type:

Article